Related scientific articles (all)

Next-generation sequencing in breast cancer: first take home messages.

Authors : Desmedt C, Voet T, Sotiriou C, Campbell PJ
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 597-604

Exploitation de la spectrométrie de masse en microbiologie : une révolution.

Authors : Martiny D, Vandenberg O
Year : 2012
Journal : J immbio
Volume : 27(4)
Pages : 177-84

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Authors : Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk HJ, Vermorken JB
Year : 2012
Journal : Radiother Oncol
Volume : 105(2)
Pages : 238-40

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors : Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(7)
Pages : 834-42

MDM4 is a key therapeutic target in cutaneous melanoma.

Authors : Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC
Year : 2012
Journal : Nat. Med.
Volume : 18
Pages : 1239-47

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors : Baselga J, Campone M, Piccart-Gebhart M, Burris HA, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN
Year : 2012
Journal : N Engl J Med
Volume : 366(6)
Pages : 520-9

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer.

Authors : Pugliano L, de Azambuja E
Year : 2012
Journal : Onkologie
Volume : 35(9)
Pages : 476-8

Causes of death and incidence of life-support techniques limitations oncological patients dying in the ICU : a retrospective study.

Authors : Meert AP, Dept S, Berghmans T, Sculier JP
Year : 2012
Journal : Journal of Palliative Care & Medicine
Volume : 2-3
Pages : 4 pages

Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Authors : Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA
Year : 2012
Journal : Ann Oncol
Volume : 23(10)
Pages : 2708-2714

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Authors : Anghel SI, Correa-Rocha R, Correa-Rochal R, Budinska E, Boligan KF, Boliganl KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem G, Fisher DE, Lévy F, Delorenzi M, Piguet V
Year : 2012
Journal : Pigment Cell Melanoma Res
Volume : 25(4)
Pages : 482-7

Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.

Authors : Herraiz C, Journe F, Ghanem G, Jiménez-Cervantes C, García-Borrón JC
Year : 2012
Journal : Int. J. Biochem. Cell Biol.
Volume : 44(12)
Pages : 2244-2252

EORTC Melanoma Group achievements.

Authors : Testori A, Suciu S, Van Akkooi ACJ, Cook M, Ghanem G, Gurunathb RK, Keilholz U, Van Kempen L, Leyvraz S, Mihm M, Newton-Bishop J, Patel P, Robert C, Schadendorf D, Schaetzen G, Spatz A, De Vries E, Eggermont AM
Year : 2012
Journal : EJC Supplements
Volume : 9(2)
Pages : 112-119

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

Authors : Rossari JR, Metzger-Filho O, Paesmans M, Saini KS, Gennari A, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : J Oncol
Volume : 2012
Pages : 417673

Atteintes orbitaires secondaires des cancers systémiques et régionaux. In: Louryan S, Lemort M, éd. Imagerie de l’œil et des voies visuelles. Montpellier, France. Sauramps Médical, 2012 (978284023832

Authors : Emonts P
Year : 2012
Journal : Book
Volume : -
Pages : 87-93

Survey concerning exposure of staff to UV radiation at four Brussels hospitals.

Authors : Lam Hoai XL, André J, Del Marmol V, Ghanem G, Sales F, Vereecken P
Year : 2012
Journal : Ann Dermatol Venereol
Volume : 139(2)
Pages : 91-102

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Authors : Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber Rd, Piccart-Gebhart M
Year : 2012
Journal : Lancet
Volume : 379(9816)
Pages : 633-40

Targeted therapies in non-small cell lung cancer: which implication in routine practice.

Authors : Meert AP, Berghmans T
Year : 2012
Journal : Thoracic Surgery Bulletin of Turkish Thoracic Society
Volume : -
Pages : 167-172

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Authors : Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F
Year : 2012
Journal : Ann Oncol
Volume : 23 Suppl 7
Pages : vii155-66

Complications of mesh repair in hiatal surgery: about 3 cases and review of the literature.

Authors : De Moor V, Zalcman M, Delhaye M, El Nakadi I
Year : 2012
Journal : Surg Laparosc Endosc Percutan Tech
Volume : 22(4)
Pages : e222-5

Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).

Authors : Azim HA, Metzger-Filho O, de Azambuja E, Loibl S, Focant F, Gresko E, Arfi M, Piccart-Gebhart M
Year : 2012
Journal : Breast Cancer Res. Treat.
Volume : 133(1)
Pages : 387-91